Literature DB >> 17905427

The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine.

Xianfeng Zhou1, Xizhen Zhang, Xianghui Yu, Xiao Zha, Qiuan Fu, Bin Liu, Xueyun Wang, Yan Chen, Yue Chen, Yaming Shan, Yinghua Jin, Yongge Wu, Junqiu Liu, Wei Kong, Jiacong Shen.   

Abstract

Nonviral gene delivery systems based on conventional high molecular weight chitosans are efficient as DNA vaccine delivery system, but have poor physical properties such as aggregated shapes, low solubility at neutral pH, high viscosity at concentrations used for in vivo delivery and a slow onset of action. Furthermore, Chitosan oligomers shorter than 14 monomers units were recently found to form only weak complexes with DNA, resulting in physically unstable polyplexes in vitro and in vivo. Here, low molecular weight chitosans with an average molecular mass of 6kDa (Chito6) have been covalently attached to gold nanoparticles (GNPs), and the potency of the resulting Chito6-GNPs conjugates as vectors for the delivery of plasmid DNA has been investigated in vitro and in vivo. After delivery by intramuscular immunization in BALB/c mice, the Chito6-GNPs conjugates induced an enhanced serum antibody response 10 times more potent than naked DNA vaccine. Additionally, in contrast to naked DNA, the Chito6-GNPs conjugates induced potent cytotoxic T lymphocyte responses at a low dose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905427     DOI: 10.1016/j.biomaterials.2007.09.007

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  24 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

2.  In vivo imaging of T cells loaded with gold nanoparticles: a pilot study.

Authors:  Hui Li; Laura Diaz; Daniel Lee; Lei Cui; Xin Liang; Yingsheng Cheng
Journal:  Radiol Med       Date:  2013-12-06       Impact factor: 3.469

Review 3.  Non-invasive administration of biodegradable nano-carrier vaccines.

Authors:  Mohd Abul Kalam; Abdul Arif Khan; Aws Alshamsan
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

4.  Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus.

Authors:  Mohamed Shehata Draz; Ying-Jie Wang; Frank Fanqing Chen; Yuhong Xu; Hadi Shafiee
Journal:  Adv Funct Mater       Date:  2016-12-14       Impact factor: 18.808

5.  Inhibition of Amphiphilic N-Alkyl-O-carboxymethyl Chitosan Derivatives on Alternaria macrospora.

Authors:  Qili Liu; Jianxin Zhang; Dong Li; Jianfeng Lang; Shasha Zai; Jianjun Hao; Xiaohui Wang
Journal:  Biomed Res Int       Date:  2018-06-11       Impact factor: 3.411

6.  Characterization and performance of nucleic acid nanoparticles combined with protamine and gold.

Authors:  Robert K DeLong; Uzma Akhtar; Michael Sallee; Brooke Parker; Stephanie Barber; Jie Zhang; Michael Craig; Richard Garrad; Anthony J Hickey; Eric Engstrom
Journal:  Biomaterials       Date:  2009-09-01       Impact factor: 12.479

7.  Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea.

Authors:  Ajay Sharma; Ashish Tandon; Jonathan C K Tovey; Rangan Gupta; J David Robertson; Jennifer A Fortune; Alexander M Klibanov; John W Cowden; Frank G Rieger; Rajiv R Mohan
Journal:  Nanomedicine       Date:  2011-01-25       Impact factor: 5.307

Review 8.  Surface chemistry of gold nanoparticles for health-related applications.

Authors:  Jiangjiang Zhang; Lei Mou; Xingyu Jiang
Journal:  Chem Sci       Date:  2020-01-15       Impact factor: 9.825

Review 9.  Gold nanoparticle mediated cancer immunotherapy.

Authors:  Joao Paulo Mattos Almeida; Elizabeth Raquel Figueroa; Rebekah Anna Drezek
Journal:  Nanomedicine       Date:  2013-10-05       Impact factor: 5.307

Review 10.  Vaccine delivery using nanoparticles.

Authors:  Anthony E Gregory; Richard Titball; Diane Williamson
Journal:  Front Cell Infect Microbiol       Date:  2013-03-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.